Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Receivables - Net (2019 - 2025)

Historic Receivables - Net for Seres Therapeutics (MCRB) over the last 4 years, with Q3 2025 value amounting to $351000.0.

  • Seres Therapeutics' Receivables - Net changed N/A to $351000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $351000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2020, which is 19211.82% up from last year.
  • Seres Therapeutics' Receivables - Net amounted to $351000.0 in Q3 2025.
  • Seres Therapeutics' Receivables - Net's 5-year high stood at $7.4 million during Q1 2025, with a 5-year trough of $351000.0 in Q3 2025.